Bird & Bird advised Bpifrance’s Large Venture on Series A financing round of Bioptimus, a specialist in AI applied to innovation in biomedicine

International law firm Bird & Bird advised Bpifrance's Large Venture on its participation in the $41 million Series A financing round of Bioptimus, a biotech company that specialises in AI applied to innovation in biomedicine.

Bpifrance's Large Venture participated alongside Cathay Innovation, who led the round, and Sofinnova Partners, an existing investor, in the Series A financing round, one year after the $35 million Seed round.

The Bird & Bird team consisted of partner Carole Bodin and associate Céline Sol for corporate aspects.

Bioptimus was advised by Jones Day, with partner Renaud Bonnet alongside associates, Jérémie Noel and Vincent Babin.

Bird & Bird, who also advised on Large Venture on its first financing round of Bioptimus, is a regular advisor to Bpifrance.

News & Deals

More News & Deals
News Bird & Bird strengthens market-leading patent practice with Anna Wolters-Höhne in Hamburg

Jul 07 2025

Read More
Deal Bird & Bird advises Brose Sitech on the acquisition of Proseat including its subsidiaries from Sekisui Kasei

Jul 07 2025

Read More
News Bird & Bird acts for Willis Mitsui & Co Engine Support Limited in Acquisition of Bridgend Asset Management Limited

Jul 04 2025

Read More
News Bird & Bird partner Bill Smith relocates to the Middle East to head the Dispute Resolution practice

Jul 02 2025

Read More
News Bird & Bird boosts Commercial team in Sweden with new partner Mårten Lindberg

Jul 01 2025

Read More
News Bird & Bird advises Gprnt on seed funding round

Jun 27 2025

Read More

Related capabilities